Watch CBS News

Vaccines

ap-21084795672571-678134-640x360.jpg

EU considers curb on vaccine exports

European leaders are expressing concern at a proposal by the European Union to block vaccine shipments to nations with already high inoculation rates. At a virtual summit Thursday, leaders, including German Chancellor Angela Merkel, balked at the idea, issuing a statement saying they were worried the move could severely disrupt global supply chains. Matina Stevis-Gridneff, the New York Times' Brussels correspondent, joined CBSN's Vladimir Duthiers and Anne-Marie Green to discuss.

cbsn-fusion-pres-biden-defends-immigration-policies-in-first-presidential-press-conference-thumbnail-678074-640x360.jpg

Immigration takes center stage for Biden

President Biden faced reporters in the White House for the first formal press conference of his presidency, taking questions on immigration, foreign policy and his political future. Mr. Biden said the COVID-19 pandemic was "the most urgent problem" facing the U.S., but the press conference showed how it has taken a back seat to other issues. CBS News chief White House correspondent Nancy Cordes reports on the press conference, and CBSN Washington reporter Caitlin Huey-Burns joins CBSN AM to discuss.

cbsn-fusion-biden-news-conference-recap-analysis-red-and-blue-2021-03-25-thumbnail-677740-640x360.jpg

Biden takes questions in first news conference

In his first formal news conference, President Biden defended his administration's policy at the U.S.-Mexico border, and revealed his plans to run for reelection in 2024. CBS News senior White House and political reporter Ed O'Keefe, CBSN Washington reporter Caitlin Huey-Burns, Associated Press White House reporter Zeke Miller and Washington Post political reporter Eugene Scott join CBSN's "Red & Blue" host Elaine Quijano with analysis.

cbsn-fusion-astrazeneca-may-have-included-outdated-information-in-covid-19-vaccine-trial-report-thumbnail-675081-640x360.jpg

Questions loom over AstraZeneca trial data

AstraZeneca may have used "outdated information" when it released data from a late-stage trial of its COVID-19 vaccine early Monday, federal officials say. The Data and Safety Monitoring Board (DSMB) said late in the day it "was concerned" about the information the British drugmaker made public about the large-scale U.S. trial of the vaccine it developed along with Oxford University. CBS News medical contributor Dr. David Agus joins "CBS This Morning" to address the news.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.